Vanguard National Trust
FBT icon

Vanguard National Trust’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Vanguard National Trust’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164K Hold
661
– – 0.01% 292
2026
Q1 		$133K Buy
+661
New +$137K 0.01% 291

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Vanguard National Trust's FBT Position: Q2 2026 in Review

Vanguard National Trust held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 661 shares worth $164K. The position accounts for 0.01% of the portfolio, ranked #292.

Vanguard National Trust first reported a position in FBT in Q1 2026 and has held it in 2 quarters since. 334 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Vanguard National Trust held 661 shares of First Trust NYSE Arca Biotechnology Index Fund worth $164K as of Q2 2026.
  • Vanguard National Trust left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Vanguard National Trust's portfolio in Q2 2026, its #292 holding.
  • Vanguard National Trust first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2026 and has held it in 2 quarters since.
  • 334 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Vanguard National Trust's 13F filing for Q2 2026, filed 13 Aug 2026.